BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29594582)

  • 1. N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery.
    Gui W; Zhang J; Chen X; Yu D; Ma Q
    Mikrochim Acta; 2017 Dec; 185(1):66. PubMed ID: 29594582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A graphene quantum dot@Fe
    Su X; Chan C; Shi J; Tsang MK; Pan Y; Cheng C; Gerile O; Yang M
    Biosens Bioelectron; 2017 Jun; 92():489-495. PubMed ID: 27839733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
    Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
    Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
    Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
    Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
    Small; 2017 Jan; 13(2):. PubMed ID: 27735129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis.
    Dong K; Zhao ZZ; Kang J; Lin LR; Chen WT; Liu JX; Wu XL; Lu TL
    Int J Nanomedicine; 2020; 15():10285-10304. PubMed ID: 33376322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
    Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
    Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyaluronic acid-graphene quantum dot nanocomposite: Potential target drug delivery and cancer cell imaging.
    Vahedi N; Tabandeh F; Mahmoudifard M
    Biotechnol Appl Biochem; 2022 Jun; 69(3):1068-1079. PubMed ID: 33932249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using hyaluronic acid-functionalized pH stimuli-responsive mesoporous silica nanoparticles for targeted delivery to CD44-overexpressing cancer cells.
    Wang Z; Tian Y; Zhang H; Qin Y; Li D; Gan L; Wu F
    Int J Nanomedicine; 2016; 11():6485-6497. PubMed ID: 27980406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.
    Lu J; Luo B; Chen Z; Yuan Y; Kuang Y; Wan L; Yao L; Chen X; Jiang B; Liu J; Li C
    Int J Biol Macromol; 2020 Mar; 146():363-373. PubMed ID: 31911174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics.
    Prasad R; Aiyer S; Chauhan DS; Srivastava R; Selvaraj K
    Nanoscale; 2016 Feb; 8(8):4537-46. PubMed ID: 26753966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
    Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
    Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.